Applying metacognitive therapy for generalized anxiety disorder to adolescents: results from an open trial with 3- and 6-months follow-up - Summary - MDSpire
Advertisement
Applying metacognitive therapy for generalized anxiety disorder to adolescents: results from an open trial with 3- and 6-months follow-up
To evaluate the effectiveness of Metacognitive Therapy (MCT) for adolescents diagnosed with Generalized Anxiety Disorder (GAD), addressing a significant gap in research.
Key Findings:
Nine out of ten patients no longer met the diagnostic criteria for GAD post-treatment, indicating a significant improvement.
Several patients also recovered from comorbid disorders, highlighting the broader impact of MCT.
Large effect sizes were observed from pre- to post-treatment on symptom measures and dysfunctional metacognitive beliefs, suggesting strong efficacy.
Session-to-session data indicated a linear decrease in distress and maladaptive metacognitive strategies, reinforcing the treatment's effectiveness.
Interpretation:
The results suggest that MCT may be an effective treatment for adolescents with GAD, with improvements maintained over time, warranting further research to confirm these findings.
Limitations:
Small sample size limits generalizability and may introduce bias.
Lack of a control group makes it difficult to attribute improvements solely to MCT, and potential biases in self-reporting could affect results.
Conclusion:
Preliminary evidence supports the efficacy of MCT for adolescents with GAD, highlighting the need for further research with larger samples to validate these findings in the context of existing treatments.
A narrative review outlines screening pathways, diagnostic challenges, and treatment strategies, including integrated care models and medication selection.
